VILINBIO

Vilin Bio Med Share Price

₹20.10 +0.05 (0.25%)

23 Dec, 2024 06:55

SIP TrendupStart SIP in VILINBIO

Start SIP

Performance

  • Low
  • ₹20
  • High
  • ₹20
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹30
  • Open Price₹20
  • Previous Close₹20
  • Volume16,000

Investment Returns

  • Over 1 Month -0.99%
  • Over 3 Month + 11.36%
  • Over 6 Month + 4.96%
  • Over 1 Year -9.66%
SIP Lightning

Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!

Invest Now

Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 28
  • P/B Ratio
  • 1.2
  • Average True Range
  • 1.23
  • EPS
  • 0.12
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.12
  • RSI
  • 46.11
  • MFI
  • 51.36

Vilin Bio Med Financials

Vilin Bio Med Technicals

EMA & SMA

Current Price
₹20.10
+ 0.05 (0.25%)
pointer
  • stock-down_img
  • Bullish Moving Average 1
  • stock-up_img
  • Bearish Moving Average 15
  • 20 Day
  • ₹20.91
  • 50 Day
  • ₹20.77
  • 100 Day
  • ₹20.58
  • 200 Day
  • ₹21.14

Resistance and Support

20.1 Pivot Speed
  • R3 20.10
  • R2 20.10
  • R1 20.10
  • S1 20.10
  • S2 20.10
  • S3 20.10

What's your outlook on Vilin Bio Med?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Vilin Bio Med Ltd has an operating revenue of Rs. 51.05 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. It is currently FORMING a base in its weekly chart and is trading around 27% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-30 Quarterly Results
2024-05-29 Audited Results
2023-11-10 Quarterly Results

Vilin Bio Med F&O

Vilin Bio Med Shareholding Pattern

64.09%
34.46%
1.45%

About Vilin Bio Med

  • NSE Symbol
  • VILINBIO
  • BSE Symbol
  • Managing Director
  • Mr. Viswa Prasad Sadhanala
  • ISIN
  • INE0L4V01013

Similar Stocks to Vilin Bio Med

Vilin Bio Med FAQs

Vilin Bio Med share price is ₹20 As on 23 December, 2024 | 06:41

The Market Cap of Vilin Bio Med is ₹28 Cr As on 23 December, 2024 | 06:41

The P/E ratio of Vilin Bio Med is As on 23 December, 2024 | 06:41

The PB ratio of Vilin Bio Med is 1.2 As on 23 December, 2024 | 06:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23